|
| 35220194 | Vulvar Melanoma in association with germline MITF p.E318K variant. | Cancer Genet | 2022 |
| 35774415 | An optimized protocol for evaluating pathogenicity of <i>VHL</i> germline variants in patients suspected with von Hippel-Lindau syndrome: Using somatic genome to inform the role of germline variants. | MethodsX | 2022 |
| 36368126 | Concurrent Pathogenic Variants of BRCA1, MUTYH and CHEK2 in a Hereditary Cancer Family. | Cancer Genet | 2022 |
| 36091175 | An integrated somatic and germline approach to aid interpretation of germline variants of uncertain significance in cancer susceptibility genes. | Front Oncol | 2022 |
| 34628056 | Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: An integrated evaluation of germline and somatic genomic results. | Eur J Med Genet | 2021 |
| 34934780 | Assessment of genomic alterations in non-syndromic von Hippel-Lindau: Insight from integrating somatic and germline next generation sequencing genomic data. | Data Brief | 2021 |
| 33303731 | Novel Pathogenic Germline Variant of the Adenomatous Polyposis Coli (APC) Gene, p.S2627Gfs*12 Identified in a Mild Phenotype of APC-Associated Polyposis: A Case Report. | Am J Case Rep | 2020 |
| 33361738 | Unexpected Pathogenic RET p.V804M Variant Leads to the Clinical Diagnosis and Management of Medullary Thyroid Carcinoma. | Am J Case Rep | 2020 |
| 30670880 | Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. | Genet Med | 2019 |
| 30287922 | Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. | Genet Med | 2019 |
| 29903880 | Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine. | Cancer Discov | 2018 |
| 30133189 | Approaches to carrier testing and results disclosure in translational genomics research: The clinical sequencing exploratory research consortium experience. | Mol Genet Genomic Med | 2018 |
| 27993725 | Point of care assessment of melanoma tumor signaling and metastatic burden from μNMR analysis of tumor fine needle aspirates and peripheral blood. | Nanomedicine | 2017 |
| 28125075 | Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study. | Genet Med | 2017 |
| 27811861 | A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories. | Genet Med | 2017 |
| 27181684 | Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. | Am J Hum Genet | 2016 |
| 27392081 | Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. | Am J Hum Genet | 2016 |
| 27460824 | The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine. | Genome Med | 2016 |
| 23835814 | Miniaturized nuclear magnetic resonance platform for detection and profiling of circulating tumor cells. | Lab Chip | 2014 |
| 24200523 | Molecular characterization of scant lung tumor cells using iron-oxide nanoparticles and micro-nuclear magnetic resonance. | Nanomedicine | 2014 |
| 23570873 | Comparison of select cancer biomarkers in human circulating and bulk tumor cells using magnetic nanoparticles and a miniaturized micro-NMR system. | Nanomedicine | 2013 |
| 22530150 | Comparison of whole genome amplification methods for analysis of DNA extracted from microdissected early breast lesions in formalin-fixed paraffin-embedded tissue. | ISRN Oncol | 2012 |
| 22764208 | Ultrasensitive clinical enumeration of rare cells ex vivo using a micro-hall detector. | Sci Transl Med | 2012 |
| 22745585 | Sensitive and direct detection of circulating tumor cells by multimarker µ-nuclear magnetic resonance. | Neoplasia | 2012 |
| 18081130 | Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. | Small | 2008 |
| 17603634 | Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization. | Neoplasia | 2007 |
| 16608261 | Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. | Nano Lett | 2006 |
| 16505285 | Limited tissue fixation times and whole genomic amplification do not impact array CGH profiles. | J Clin Pathol | 2006 |
| 16751137 | Cellular imaging and surface marker labeling of hematopoietic cells using quantum dot bioconjugates. | Lab Hematol | 2006 |
| 17163724 | High throughput quantification of protein expression of cancer antigens in tissue microarray using quantum dot nanocrystals. | Nano Lett | 2006 |